Icotinib Hydrochloride
Product Specifications
CAS Number
1204313-51-8
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Purity
0.9989
Bioactivity
Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.
Smiles
Cl.C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1
Molecular Formula
C22H22ClN3O4
Molecular Weight
427.88
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9390574 Inquire
Cavy Cholesterol 24-Hydroxylase (CYP46A1) ELISA Kit
Sign In for Pricing
View Details NBP3-08763AF750 100 µL
Rabbit Monoclonal gp96/HSP90B1/GRP94 Antibody (HSP90B1/3168R) [Alexa Fluor 750]
Sign In for Pricing
View Details ![4-[2-[[6-Amino-9- (N-ethyl-b-D-ribofuranuronamidosyl) -9H-purin-2-yl]amino]ethyl]benzenepropanoic acid monosodium salt](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
295295-01 5 mg
4-[2-[[6-Amino-9- (N-ethyl-b-D-ribofuranuronamidosyl) -9H-purin-2-yl]amino]ethyl]benzenepropanoic acid monosodium salt
Sign In for Pricing
View Details